Jennifer Tousignant
Consigliere Generale presso VIRIDIAN THERAPEUTICS, INC.
Posizioni attive di Jennifer Tousignant
Società | Posizione | Inizio | Fine |
---|---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Consigliere Generale | 15/02/2024 | - |
Storia della carriera di Jennifer Tousignant
Precedenti posizioni note di Jennifer Tousignant
Società | Posizione | Inizio | Fine |
---|---|---|---|
XILIO THERAPEUTICS, INC. | Consigliere Generale | 01/01/2020 | 01/11/2020 |
TESARO INC | Consigliere Generale | 01/04/2016 | 01/10/2019 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
SANA BIOTECHNOLOGY, INC. | Consigliere Generale | 01/09/2022 | - |
Formazione di Jennifer Tousignant
Suffolk University Law School | Graduate Degree |
University of Virginia | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
General Counsel | 4 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
SANA BIOTECHNOLOGY, INC. | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Tousignant
- Esperienza